A study using genetically modified zebrafish to visualize early events involved in development of human atherosclerosis describes an efficient model – one that the researchers say offers many applications for testing the potential effectiveness of new antioxidant and dietary therapies. …Read the full story from the UCSD Newsroom
Leader of the research team is Yury Miller, MD, PhD, associate professor of medicine in the Division of Endocrinology and Metabolism. His Department of Medicine coauthors include Joseph L. Witztum, MD, professor in the same division; and Sotirios “Sam” Tsimikas, MD, FACC, professor in the Division of Cardiology. | Read the article online in the Journal of Clinical Investigation.